New paper coming out with Josh Feng! Read Josh’s thread if you are interested in drug price negotiations!

People stick to their initial drug choices even when new treatments become available. In the March 2024 issue of REStat by Josh Feng, Josh Feng. zurl.co/2bll

Is it weird that the FTC complaint against PBMs is the most riveting evening read I have done in years? ftc.gov/system/files/f…

New paper out, led by Pragya Kakani! Check out the podcast at the end of the thread--just the right length for your work commute

I have a few overdue research updates I will post about in the next week or two. But first, our department HMS HCP is hiring a postdoc to work with me on pharma topics. Posting here: benny.aeaweb.org/joe/listing.ph… Please circulate, and feel free to reach out with any questions!

🚨 What happens when the gov't cuts prices on medical technologies? New research (w/ Yunan Ji) finds a 61% price cut led to: 75% drop in innovation (may fully offset savings) 49% fewer new firms 28% more production moved overseas 3x repair/replacement rate 🧵(1/n)

📢hi #econtwitter - if you are still here, I am looking for ONE paper to complete an organized session for #ASHEcon2025 on the topics of ~PE, corporate ownership, vertical integration, mergers & acquisitions in health care, etc.

I'm the chair of the prescription drug area this year. Please send in all your pharma papers! The more submissions an area receives, the more we accept. If you need help putting together a session, check the single abstract listing (link at ashecon.org/2025-nashville…) or email me!

Glad to serve the new "Innovation & Digitization" area.🚀 Please send in all your relevant papers! The more submissions an area receives, the more we accept. Individual abstracts and organized sessions are all welcome! Single abstract listing (ashecon.org/2025-nashville…) / email me!

Calling all PhD students interested in innovation -- Submit your work to the 8th Annual Wharton Innovation Doctoral Symposium; highly recommended! mackinstitute.wharton.upenn.edu/students/whart…

There's still time:) Check out the single abstract listing (ashecon.org/2025-nashville…), or email me if you need papers to round out a session on prescription drugs!

I have terrible news. I took a sneak peek at current submission numbers for ASHEcon and the Prescription Drugs area is not number one. We're not even on the podium. Are we gonna let Health Systems and Health Care Financing win?

Many industries where the government is a major regulator, purchaser, or supplier suffer from severe worker shortages (e.g., healthcare, transportation, education, public safety). A quick thread on our new The Review of Economics and Statistics (REStat) showing how government payment incentives can help: 1/N

Postdoc alert! The deadline for the position at HMS HCP is in a little over two weeks. If you are on the econ/health policy market and are interested in pharma, please consider applying! aeaweb.org/joe/listing.ph…

This year's Econ job market has, by all accounts, been brutal. If you're still not sure what you're doing next year, applying for external funding to continue your work is a great way to buy yourself time & options. It's a way to "build your own post-doc." Check out AV's open

Congratulations to Josh Feng, Emma Dean, and Luca Maini on being selected for the 2025 cohort of #NIHCM Research Grantees! Read more in the release: bit.ly/ResGr25 | #NIHCMGrants2025